Drug Screening Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Quest Diagnostics Incorporated, Abbott Laboratories, Quidel Corporation, F. Hoffmann-La Roche

The Drug Screening market is estimated to grow at a CAGR of 16.5% over the forecast period, from USD 5.6 billion in 2021 to USD 11.2 billion in 2027. (2022 - 2027).

Drug Screening Market Overview

Drug screening is the process of detecting illegal and prescription drugs in blood, urine, and other bodily fluids. The analysis and detection of performance-enhancing pharmaceuticals used by professional athletes, such as steroids and HGH, in order to boost stamina and performance during competition is referred to as a drug screening process.

Heroin, cannabis, cocaine, methamphetamines, methadone, and amphetamine are some of the most often used illegal drugs. Many countries are concerned about the rising prevalence of such drug consumption around the world. For example, according to the National Institute on Drug Abuse (NIDA), an estimated 22.6 million people in the United States used illicit drugs in 2010, accounting for 8.9% of the country's entire population.

The rising prevalence of drug addiction and illicit drug consumption is likely to boost the worldwide drug screening market over the forecast period. Furthermore, rising crime rates connected with drug usage are expected to enhance drug screening adoption, which will fuel the worldwide drug screening market's rise.

Industry News and Updates

May 5, 2020: Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine--

Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.

Drug Screening Market Growth Drivers

• Increasing use of alcohol and drug consumption and underlying risks is increasing law enforcement.


• Stringent regulation in North America to keep the attractive quotient of the region intact.


• Growing drug rehabilitation centers translate to increasing adoption of drug screening devices.

What are the major Applications, Types and Regions for Drug Screening Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Immunoassay Analyzers


• Chromatography


• Breath Analyzers


• Rapid Testing Devices


• Assay Kits and Reagents

By Application, it is segmented into

• Hospitals


• Research Institute


• Biotechnology & Pharmaceutical Companies


• Others

Drug Screening Market Regional Analysis

The drug screening market is divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World. North America had a 48.2% share of the overall market in 2020, followed by Europe. Factors such as the rising consumption of illicit drugs, the availability of government funding to combat drug abuse, laws supporting drug screening, the rising burden of accidents caused by alcohol impairment, and the presence of key players in the region are all contributing to the North American market's dominance. Asia Pacific is predicted to grow at a rapid pace during the projection period, with China and India leading the way. A rising number of drug addicts, the development of advanced drug and alcohol screening devices, increased awareness of the importance of alcohol and drug screening, and an increase in government and private institute initiatives aimed at improving the drug detection system are all expected to contribute to the drug screening market's growth in Asia Pacific.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Drug Screening Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Drug Screening Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Drug Screening Market report scope?

Frequently Asked Questions

What is the growth rate of Drug Screening Market?

The Drug Screening Market is growing at a CAGR of 16.5% over the next 5 years.

Who are the key players in Drug Screening Market?

Quest Diagnostics Incorporated, Abbott Laboratories, Quidel Corporation, F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., LabCorp, Drägerwerk AG & CO. KGaA, Clinical Reference Laboratory (CRL), Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc.

What are the significant types of Drug Screening Market?

Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents

What are the major end-use applications of Drug Screening Market?

Hospitals, Research Institute, Biotechnology & Pharmaceutical Companies, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.